FDA Sends Medtronic Warning Over Diabetes Facility Issues
The U.S. Food and Drug Administration has found that medical technology company Medtronic has various lapses at a California-based facility focused on diabetes treatment, the company announced on Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article